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Abstract
We study a simple exogeneity test in count data models with possibly endoge-
nous multinomial treatment. The test is based on Two Stage Residual Inclusion
(2SRI). Results from a broad Monte Carlo study provide novel evidence on impor-
tant features of this approach in nonlinear settings. We nd di¤erences in the nite
sample performance of various likelihood-based tests under correct specication and
when the outcome equation is misspecied due to neglected over-dispersion or non-
linearity. We compare alternative 2SRI procedures and uncover that standardizing
the variance of the rst stage residuals leads to higher power of the test and reduces
the bias of the treatment coe¢ cients. An original application in health economics
corroborates our ndings.
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1 Introduction
Instrumental variables (IV) methods are the established solution to the problem of
endogeneity of regressors in linear models. However, it is well known that IV estimators
imply an e¢ ciency loss that might be substantial with respect to Ordinary Least Squares
estimators. This explains the great attention received by the Hausman test for endogeneity
(1978), and by its computationally simple regression-based form. This consists of a two
stages procedure: rst stage residuals are computed from reduced form estimation and
are then inserted as additional regressors in the second stage equation for the outcome
of interest. This method, known as two stage residual-inclusion (2SRI), tests the null
hypothesis of exogeneity of a subset of regressors by way of a variable addition test, i.e.
checking whether the coe¢ cients of the rst stage residuals are equal to zero in the second
stage structural equation.
Accounting for endogeneity in non linear models is a challenging issue in econometrics.
Wooldridge (2002, 2011) and Terza (2008) point out that the application of IV methods in
this context is not straightforward, since two stages estimators are not in general consistent
for the structural parameters of interest. Despite some recent contributions suggest distri-
bution free semiparametric approaches (see Abrevaya et al, 2010, and the references cited
there), the most common practice to handle endogeneity in the nonlinear framework con-
sists in formulating some parametric distributional assumptions on both the endogenous
regressors and the outcome variable. Inference on the parameters of interest and on the ex-
ogeneity status of the regressors is performed through Maximum Likelihood (ML) method,
its validity requiring correct specication of the model. Wooldridge (2011) shows that in
some non linear models with endogenous regressors ML estimation under misspecication
-i.e. Quasi ML estimation- has some robustness properties. Wooldridge (2011) also derives
a class of two step tests for exogeneity of multiple -and possibly discrete- regressors. The
conceptual and computational simplicity of the two step approach to exogeneity testing
in nonlinear models makes it extremely appealing for the applied researcher.
We consider here the problem of endogeneity in count data models. The empirical
microeconometrics literature, and health econometrics in particular, devoted much atten-
tion to this class of non linear models. For instance they are extensively used to represent
healthcare demand through the number of doctor visits. Endogeneity is likely to arise
due to unobserved heterogeneity a¤ecting both the outcome and the regressors, possi-
bly stemming from unobserved agentscharacteristics or misreporting. Deb and Trivedi
(1997), Kenkel and Terza (2001), Mullahy (1997), Windmeijer and Santos Silva (1997),
Van Ophem (2000), Miranda (2004), Fabbri and Monfardini (2009), Cheng and Vahid
(2010), Bratti and Miranda (2011) are some examples dealing with endogenous binary
regressors. Recently, some attention has been devoted to the case of count data models
with multinomial endogenous regressors. Deb and Trivedi (2006) propose a simulation
based full maximum likelihood method for single equation count data models (generalized
to the case of multivariate counts by Fabbri and Monfardini, 2011). Zimmer (2010) adopts
instead a two step procedure, following the suggestion of Terza et al (2008). This latter
study stresses that in many non linear contexts replacing predicted endogenous variables
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in the second stage leads to inconsistent estimators, and points to 2SRI to obtain valid
inference, including exogeneity tests.
This paper aims at establishing whether exogeneity tests based on 2SRI represent a
viable alternative to detect endogeneity in count data models with multinomial endoge-
nous regressors. In this context, 2SRI tests are much easier to implement than maximum
likelihood approaches that require simulations and are computationally intensive. We de-
velop a broad Monte Carlo Study to assess the nite sample properties of 2SRI exogeneity
tests. In our framework, endogeneity is represented by alternative specic latent factors
entering both the count outcome equation and the multinomial treatment model. This
formalization of endogeneity is germane to Terza (2008) - based on 2SRI - and Deb and
Trivedi (2006) - based on FIML estimation.
Our Monte Carlo experiments produce novel evidence on important features of the 2SRI
procedure, enhancing existing simulation studies conducted by Terza (2008) and Staub
(2009) for the case of count regressor with dychotomous endogenous explanatory variable.1
We start by evaluating the performance of di¤erent likelihood based tests, namely Wald
and Likelihood Ratio, under correct specication and various form of misspecication,
ranging from neglecting over-dispersion to neglecting non-linearity. Then we compare
alternative 2SRI tests, adopting alternative denitions for the rst stage residuals, and
spot relevant di¤erences in their performance. This is a relevant aspect, since the rst
stage estimation involves multinomial discrete choice models, where no consensus exists
on the denition of the error term (see Pagan and Vella, 1989). Finally, we bring our
conjectures and ndings to real data, and apply the 2SRI procedure to an original case
study in health economics. We use data from an important French Survey to model the
individual annual number of doctor visits allowing for healthcare insurance status to be
endogenously determined. The results of this application are coherent with the main
nding of our Monte Carlo investigation.
The remaining of the paper is structured as follows. Section 2 sets a general parametric
representation of endogeneity in nonlinear models. Section 3 describes the count regression
with multinomial endogenous treatment. Section 4 presents the 2SRI estimator/test we
study. The design of the Monte Carlo experiment is illustrated in Section 5, together with
the simulation results. Section 6 is devoted to the application of the procedure to a model
of healthcare demand with endogenous insurance. Section 7 concludes.
2 A parametric representation of endogeneity in non-
linear models
We consider the non linear conditional mean of the outcome y:
1In a related work Kapetanios (2010) analyses through a Monte Carlo study the peformance of some
new Hausman-type tests for exogeneity in nonlinear threshold models.
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E[yijxi;xei;qi] = M(xi + xeie + qi) (1)
= M(xi +
SX
s=1
sxeis +
SX
s=1
sqis) (2)
where M() is a non-linear function, xi is a set of K exogenous regressor, xei is a set of S
covariates (either discrete or continuous) possibly correlated with a set of S unobservable
confounders qi, hence endogenous. Following Terza et al. (2008), we represent endogeneity
of regressors xei by an idiosyncratic inuence of the same latent factors qi on both yi and
xei in possibly non linear reduced form regressions:
xesi = rs(zis) + qsi s = 1; :::; S (3)
where zi = [xi wi], and wi is a set of at least S instrumental variables satisfying all the
necessary assumptions.
In this setting, the hypothesis of exogeneity of regressors xesi; s = 1; :::; S can be
formulated as:
H0 : 1 = 2 = ::: = S = 0
Taking a fully parametric approach to inference, let the density of the outcome condition-
ally to endogenous regressors, exogenous covariates and latent factors be:
f(yijxi;xei;qi)
and the marginal density of endogenous regressors conditionally to exogenous covariates
xi, identifying instruments wi and latent factors qi be denoted as:
g(xeijxi;wi;qi)
The two above distributions can be combined into a joint distribution of the type:
Pr(yi;xeijxi;wi;qi) = f(yijxi;xei;qi) g(xeij;xi;wi;qi) (4)
Unobservability of qi can be handled by way of some parametric distributional assump-
tions, taking them as i.i.d draws from density h(qi). Their distribution is integrated out
via simulation, obtaining the joint density of the observable variables:
Pr(yi;xeijxi;wi) =
Z
f(yi;xeijxi;wi;qi)h(qi)dqi (5)
Estimation is performed maximizing a simulated log-likelihood function. Provided that
the factor loading parameters 1; 2; :::; S are identied, a test for exogeneity of the vector
xei can be carried out with the usual maximum likelihood-based tests. This is a full infor-
mation maximum likelihood (FIML) procedure since all equations are jointly estimated,
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and it is well known to achieve asymptotic e¢ ciency properties under correct distribu-
tional assumptions. Notice, however, that e¢ ciency comes with an heavy computational
cost.
An easier test for exogeneity of xei can be carried out resorting to the so called two
stage residual inclusion procedure (2SRI). Two Stages Residual Inclusion and Two Stages
Prediction Substitution (2SPS) are the non-linear counterparts of the linear Two Stages
Least Squares (2SLS) approach. While 2SPS substitutes the endogenous regressors in the
structural equation with their consistent estimates obtained in the rst stage (mimick-
ing 2SLS in the nonlinear case), 2SRI keeps the endogenous regressors in the outcome
equation and substitutes the unobservable confounders with residuals obtained from the
reduced equation. Wooldridge (2002) and Terza et al. (2008) emphasize that, when the
conditional expectation is nonlinear, 2SPS is generally an inconsistent procedure, while
2SRI allows to get consistent estimates of the structural equation parameters.2 In our case
of full parametric assumptions the 2SRI approach involves separate maximum likelihood
estimation of both the rst and the second stage equations (and it amounts to limited
information maximum likelihood, cf. Wooldridge, 2011).
After estimation of the reduced form equations, predictors of the endogenous regressors
are obtained as:
x^esi = rs(zi^s) (6)
Residuals, which estimate qsi, are computed as follows:
q^si = xesi   rs(zi^s) (7)
and are plugged inside the structural equation. The parameters s s = 1; :::; S are the
coe¢ cients associated to the estimated residuals q^si, so that the exogeneity test amounts
to a variable addition test in the second stage equation, which can be easily performed
with likelihood-based tests.
When the functions M() and rs() in (1) and (3) are linear, 2SRI coincides with the
regression-based exogeneity test proposed by Hausman (1978), thus the 2SRI procedure
can be seen as an extension of the Hausman test to the non-linear framework. Notice that
the non linear function rs() allows for endogenous regressors of di¤erent nature in xei,
including multinomial treatment. In this case (3) will describe its relationship with the
unobservable confounders as a multinomial response model.
Testing exogeneity of xei with 2SRI is a more practical alternative with respect to FIML
approaches. However, little is known about its properties in nite samples. Is the two
step procedure reliable, so that practitioners can exploit its computational advantages?
Are there ways to conduct 2SRI outperforming alternative possibilities? In the following
sections we answer to these questions. Despite we analyse the specic case of a count
2The proof of consistency is carried out by Terza et al. (2008) using the theory of two stages optimiza-
tion estimators, of which 2SRI can be seen as a special case.
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outcome, some results of ours might also be informative for other nonlinear models with
potentially endogenous multinomial regressors.
3 A count data model with endogenous multinomial
treatment
In the Data Generating Processes we will specify in the next section, the multinomial
treatment a¤ects the count outcome equation trough di, a set of J dummies for the
J + 1 mutually exclusive alternatives in the choice set. Endogeneity is pinned down
using the same alternative specic latent factors qij, in the treatment and the outcome
equations. This formulation adapts the proposal of Deb and Trivedi (2006) to the general
representation of endogeneity presented in the previous section.
Let the density for the count outcome conditionally to exogenous variables, treatment
and latent factors be written as:
f(yijxi;di; qi) = f (i;) (8)
In order to accomodate for overdispersion in the data, f() is assumed as a Negative
Binomial type-2 density function with rate parameter : Thus, (8) can be re-written as:
f(yijxi;di; qi) =
 (yi +  )
 ( ) (yi + 1)

 
i +  
  i
i +  
yi
(9)
where  is the overdispersion parameter, and the conditional mean for the outcome takes
the usual exponential form:
i = E(yijxi;di; qi) = exp
0@x0i + JX
j=1
jdij +
JX
j=1
jqij
1A (10)
In the above equation xi is a vector of exogenous observable characteristics of individual
i which do not vary among alternatives, and  is the conformable vector of coe¢ cients. The
multinomial treatment enters the model trough di, the set of J dummies, dij indicating the
treatment alternatives. qi is a vector of J unobservable latent factors qij, with associated
factor loadings j, which potentially a¤ect both the outcome and the treatment, generating
endogeneity in the outcome model.
The equation for the multinomial treatment is derived from a random utility model,
according to which each individual chooses the treatment which maximizes her indirect
utility. Indirect utility for individual i from alternative j can be expressed as follows:
V ij = z
0
ij + qij (11)
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where zi is a vector including the exogenous covariates in xi in (10) plus a set of instru-
ments, and j is the vector of associated parameters for the alternative j. Alternative
j is chosen by individual i i¤ V ij  V ik;8k 6= j: The dummy dij in (10) takes value 1 if
alternative j is chosen, 0 otherwise. Utility from alternative j = 0 is normalized so that
V i0 = 0.
We specify qij as i:i:d Type 1 Extreme Value erros (logistic after normalization). This
amounts to assume a Multinomial Logit (MNL) representation for the probability of the
treatment, which can be written as follows:
Pr (dij jzi) = exp (z
0
ij)
1 +
JP
k=1
exp
 
z0ik
 for j = 0; 1; :::; J (12)
4 The 2SRI estimator
4.1 First stage
In multinomial discrete choice models there is no consensus about the denition of
errors and residuals. With our notation, let cPr (dijjzi) be the predicted probability of
choosing alternative j, obtained after estimation of a multinomial response model. The
most obvious denition of residuals is what we name, following Cameron and Windemejer
(1996) raw residuals (adopted for example by Terza et al.,2008 and Staub, 2009):
bqRij = dij   cPr (dij jzi) for j = 0; 1; :::; J (13)
Alternatively, Pagan and Vella (1989) suggest a standardized version of the residuals, with
unit variance, we call standardized residuals
bqSij = cPr (dij jzi) 1=2 1  cPr (dij jzi) 1=2 dij   cPr (dij jzi) for j = 0; 1; :::; J (14)
In the absence of any guidance on the choice between these two alternatives, in our Monte
Carlo study we will compare them, to nd out whether standardization improves the
performance of the exogeneity test.
4.2 Second stage
Once the MNL for treatment is estimated, we have available two types of residuals for
each alternative (raw, R, and standardized, S), based on expressions (13) and (14), say:
bqrij = dij   cPr (dijjzi) for j = 0; 1; :::; J r = R; S
These residuals are then added to structural equation for the outcome, substituting for
the unobservable latent factors, so that equation (10), describing the conditional mean for
y, can be re-written as follows:
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E(yijxi;di; q^ri ) = exp
0@x0i + JX
j=1
jdij +
JX
j=1
jbqrij
1A r = R;S (15)
This second stage model is estimated via maximum likelihood and the exogeneity test for
the hypothesis H0 : 1 = ::: = J = 0 is carried out through Wald, Likelihood ratio and
Lagrange Multiplier tests under three di¤erent specication scenarios.
4.2.1 Correct specication
The conditional density is assumed to be the NB2 distribution (9), with conditional
mean (10).
4.2.2 Neglecting over-dispersion: Poisson estimator
The conditional density is assumed to be a Poisson distribution, setting  = 0 in
the NB2 distribution (9), while mantaining the same formulation (10) for the conditional
mean. Despite this specication does not allow for the existing overdispersion of the data,
the Poisson PML estimator is still consistent for the conditional mean of the outcome,
which remains the same. Estimating the model with this alternative version of the 2SRI
estimator allows us to assess the robustness of the Poisson specication under di¤erent
degrees of overdispersion of the outcome.
4.2.3 Neglecting non linearity: OLS estimator
The equation describing the conditional mean for y is substituted by the following
linear approximation:
E(yijxi;di; ^ i) = x0i +
JX
j=1
jdij +
JX
j=1
jbqrij r = R;S (16)
In this setup the exogeneity test is conducted through a F test. This will allows us to
evaluate to what extent the count nature of the outcome can be ignored resorting to the
linear approximation.
5 The Monte Carlo Study
In order to investigate the nite sample properties of the 2SRI exogeneity tests, we run
simulations under di¤erent Data Generating Processes (DGPs) described below.3
3The study has been conducted using STATA 12. Programming code and user-written routines are
available on request.
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5.1 Experimental design
Random utilities are computed by way of a discrete choice model; the j   th status
dummy assumes value 1 if its utility has the highest value among the J +1 alternatives, 0
otherwise. After having generated the dummies representing the multinomial treatment,
the conditional expectation of the count dependent variable, y, is obtained by random
sampling from a Negative Binomial type-2 distribution. This is obtained as a Poisson-
Gamma mixture with parameter i = ii, where i is the conditional mean of a Poisson
random variable, taking the usual exponential form, and i is a random draw from a
Gamma distribution. The number of alternatives in the multinomial treatment model,
J + 1, is set to three: j = 0; 1; 2, so that only two dummies are included inside the
conditional mean for the outcome.
In order to evaluate size and power properties of the exogeneity tests, we build two dif-
ferent DGPs under endogeneity and exogeneity of the multinomial treatment. Both DGPs
we analyse include logistic latent factors, but they di¤er for the degree of overdispersion.
Under DGP2 the count variable is set to be much less overdispersed - i.e. its variance is
closer to its mean, compared to the count variable generated under DGP1.4 The sample
size, N , is set to 5.000 observations, which is a realistic size for application of count data
models to microeconometric data. The size and power properties of the 2SRI exogeneity
tests are evaluated on 5:000 replications of the test statistics.
The following table describes the distribution of the pseudo random variables and the
parameter values in our experimental setting.
4We obtain these pattern by increasing the scale parameter of the mixing gamma distribution and by
lowering the constant inside the conditional mean of the count, as detailed in the table describing the
experimental design.
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Description of experimental design
DGP 1, DGP 2
di1 = 1 if V i1 = max (V

i0; V

i1; V

i2), = 0 otherwise
di2 = 1 if V i2 = max (V

i0; V

i1; V

i2), = 0 otherwise
V i0 =0
V i1 = 0:025+0:5 obsi + 0:5inst1i + 0:25 inst2i + qi1
V i2 = 0:25 + 0:1obsi+0:5inst1i+0:5 inst2i+qi2
obsi i.i.d N(0; 1), observable characteristic
inst1i dummy variable, I[U(0; 1) < 0; 5] - rst instrument
inst2i N(0; 1) - second instrument
q1i; q2i i.i.d draws from a logistic density
f(yijxi;di;qi) =  (yi+ ) ( ) (yi+1)

 
i+ 
  i
i+ 
yi
Mixing distribution i Gamma( ; 1 )
i =exp (k + obs obsi + d1 di1 + d2 di2 + 1 qi1 + 2 qi2)
obs = 0:5; d1 = 0:4; d2 = 0:8
Endogenous treatment 1   0:1;2 =  0:5
Exogenous treatment 1 = 2 = 0
DGP 1  = 1;k = 1
DGP 2  = 3;k =  1
In Appendix 1 we report basic descriptives of the treatment dummy variables and
of the count variables under the di¤erent DGPs. Notice that the marginal probability
distribution of the dummies is kept constant over the di¤erent data generation processes.
DGP2 involves a much lower degree of overdispersion than in DGP1, as it can be observed
comparing the variance and the mean of the two count variables. Concomitantly, under
DGP2 the count variable displays the "excess of zeros" pattern wich is often encountered
in applications.
5.2 Results
5.2.1 Exogeneity Test
In Table 1 we report rejection frequencies over the 5000 Monte Carlo replications of
the three asymptotycally equivalent Wald, Likelihood Ratio (LR) and Lagrange Multplier
(LM) tests under correct specication of the estimated model, i.e. when the estimated
model is NB2. We present two versions of the Wald test, the rst of which is based
on a Murphy-Topel corrected Variance-Covariance Matrix. This is evaluated taking into
account that the model estimated in the second stage involves generated regressors, namely
the rst stage estimated residuals. We have derived the correction when the rst stage
model is multinomial adapting the procedure suggested by Hole (2006).5 The Table reveals
a general very good performance of all 2SRI tests, in terms of both size and power for both
5Analytical results and STATA code are available upon request.
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analysed DGPs. If we compare the test performance among the two denitions of residuals
we notice an improvement of power properties of Wald corrected test when switching from
"raw" to "standardized" version. A very slight power gain is associated to the use of
standardized residuals also for the non corrected version of the Wald for the LM test.
The improved general performance with standardized residuals is an interesting pattern
we spot here and in the following results, and to which will devote further attention later.
Table 1 here
Table 2 presents the results concerning the e¤ects on exogeneity tests of the rst mis-
specication we study. The tests are here obtained estimating a Poisson regression model
while both DGPs involve a NB2 process. As the count variable exhibits greater overdisper-
sion under DGP1 than under DGP2, the Poisson estimator, which assumes equidispersion,
is "more misspecied" under DGP1. In this latter scheme, the bad consequences of mis-
specifying overdispersion are serious for all tests but Lagrange Multiplier, which proves to
be fairly robust, with higher power still obtained with standardized residuals. The em-
pirical size of the Wald test evaluated without Murphy-Topel correction, and that of the
Likelihood Ratio test are dramatically a¤ected by misspecication of overdispersion, with
rejection frequencies that imply huge probabilities of rst type error (reject exogeneity
when this is true). Moreover, the Wald test with corrected variance is found to loose any
power of spotting true endogeneity. The robustness of LM test means that the quantities
involved in its computation (score function of the unrestricted model, restricted estimator)
are less a¤ected by overdispersion parameter than the quantities involved in LR (restricted
and unrestricted loglikelihood functions) or non-corrected Wald tests (unrestricted estima-
tor). Some di¤erent mechanism is instead likely to a¤ect the Wald test based on Murphy
Topel variance, annihilating both its size and power properties. Under DGP2, on the con-
trary, all tests display reasonable empirical size and power. Remarkably, the best power
results of corrected Wald test and LM are still achieved resorting to standardized residuals,
conrming the pattern already spotted under correct specication.
Table 2 here
Table 3 reports the results obtained when the estimated model is linear, thus neglecting
the count nature of the dependent variable. Performing the test within OLS estimation
delivers very misleading results. It proves quite important to implement the test specifying
a count density, rather than resorting to the linear approximation of the conditional mean
implyed by linear regression. Empirical sizes are generally much higher than their nominal
counterparts, hindering any reasonable inference on the exogeneity status. Similarly to
the Poisson estimator case, failure of the test in recognizing exogeneity of the treatment
is likely due to the inability of the estimator to t the overdispersed structure of the data.
Indeed, over-rejection of the true exogeneity hypothesis is less pronounced, despite still
serious, under DGP2, where the count is less overdispersed.
Table 3 here
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5.2.2 Comparing raw and standardized rst stage residuals
In this section we analyse more carefully the di¤erent nite sample performance of
the exogeneity tests obtained including the two alternative denitions of residuals in the
second stage, i.e. raw versus standardized. In Figures 1 and 2 in Appendix 2 empirical
power is plotted against nominal size for di¤erent values of the latter. The interesting
part of the plot is for small values of nominal size that will be chosen in practice (usually
nominal size is set below 0.10). The higher power of the test obtained standardizing the
rst stage residuals is a clear pattern for all test statistics under both DGPs, conrming
that there is a gain in using the standardized residuals.
To get some insights on the source of this gain we exploit our simulation setting to
compare the generated errors of the discrete choice model and their two alternative es-
timates represented by raw and standardized residuals respectively. To this purpose, we
perform the following elaborations. First, we regress the generated errors used to simulate
the two random utilities attached to alternatives 1 and 2 (named latent 1 and latent 2
in the following graphs) against the two alternative denitions of residuals. In the upper
part of Figure 3 in Appendix 2 we plot the true latent errors versus the tted latent errors
obtained using as regressor the two alternative denitions of residuals. In the bottom
part, we plot together the density of the true latent errors, the raw residuals and the
standardized residuals.
Taken together, these plots reveal that standardizing the variance of the residuals
allows for a better overlap with the range of possible values assumed by the latent error
component. Indeed, standardization will always increase the variance of raw residuals,
which is lower than one by denition. This represents a possible explanation for the
better ability of the standardized residuals to approximate the latent utility error and for
the better performance of the exogeneity tests based on this denition of residuals.
5.2.3 Some remarks on the coe¢ cients estimators
As a by-product of our analysis on the properties of the exogeneity test, we report in
Tables A2-A3 in Appendix 3 the mean of the estimated coe¢ cients and their standard
errors obtained trhough the 5000 replications of the Monte Carlo experiments. We draw
our attention on the behaviour of the dummy coe¢ cients estimators which represent the
treatment e¤ects of interest. The coe¢ cients display little bias under exogeneity when
the estimation is based on either NB2 (Table A2) or Poisson (Table A3), conrming its
well known consistency property under correct specication of the conditional mean.6
However, inference on the treatment coe¢ cients is -not surprisingly- much more di¢ cult
under endogeneity. Here, the treatment coe¢ cients exhibit some bias, despite the quite
large sample considered (N = 5000), with di¤erent magnitude across DGPs and estimated
models. In order to get a measure of the total bias of the two treatment coe¢ cients we
build a synthetic measure given by the sum of the absoute value of the bias over the two
coe¢ cients. Figure 4 plots the distribution of this measure of total bias of the second stage
6We do not include for brevity results on OLS estimators, which turn out to be tremendously biased.
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ML estimators across estimated models and DGPs. Interestinlgy, the bias is always lower
when estimation involves the standardized version of the rst sage residuals, corroborating
the inference gain already spotted for the exogeneity test. A nal remark concerns the
Murphy Topel correction. As expected, the corrected standard errors are higher than their
non corrected counterpart, but become excessively high in the presence of misspecication.
This calls for some caution before basing inference on the modied variance estimator in
applied contexts.
6 An application to healthcare demand
Count data models with possibly multinomial endogenous treatment arise quite easily
in the Health Economics literature. Here demand naturally comes as a count (for physician
visits or hospital admissions) and polichotomous health insurance status is an endogenous
treatment of paramount interest. To provide a vivid example of how the two alternative
2SRI strategies fare in the applied econometrics practice we revisit and update the French
case study on the e¤ect of complementary health insurance on health care utilization
originally explored by Buchmueller et al. (2004).
Social Security insurance (Sècuritè Sociale) nanced out of personal income tax covers
most of individual healthcare expenditure for legal residents of France. Co-pay are cus-
tomarily levied for general practitioner or specialist visits, hospital stay, or prescription
drugs to moderate moral hazard. To get rid of most of these copayments French citizens
purchase complementary health insurance (CHI) on a voluntary basis (individually pur-
chase) or within an employer-sponsored set-up (employer insured). CHI plans enroll 85%
of the French population and fund about 13% of total health care expenditure. Similarly
to Buchmueller et al. (2004) our exercise aims at assessing the impact of the CHI status
on physician visitsutilization. We di¤er in that we allow for a di¤erential impact of the
individually purchased and the employer provided CHI with respect to the benchmark
case of no complementary coverage. Accounting for endogeneity of the treatment and
modeling the dependent variable as a count represent the biggest improvements on the
previous study.
We use data from the 2006 wave of the Enquète sur la Santé et la Protection Sociale
(ESPS), a national household survey conducted by IRDES. The full sample contains data
for 22725 individuals. We restrict our analysis to individuals aged between 25 and 75.
After excluding those who have not completed the healthsection of the questionnaire
or have missing data on key regressors we end up with a nal estimation sample of 6455
observations. Table 4 presents the distributions of our utilization measure, i.e. counts for
visits to any physician (in the 12 months before the interview), and the treatment variable,
i.e. availability of a Complementary Health Insurance. 55% of the sample receives CHI as
part of work total compensation while 34% purchases it deliberately in the market. 6% of
the sample is covered by CMU-C (Couverture Maladie Universelle Complementaire). This
plan was introduced in 2000 by the French Government to improve the non-elderly poor
access to health care. CMU-C beneciaries are asked no co-pay at the point of use. Eligible
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individuals are those with a household income below a given threshold (e587 per adult
equivalent per month in 2005, see Grignon, Perronnin and Lavis, 2008). Upon control for
income per adult equivalent we assume this CHI status as conditionally exogenous.
Table 4 here
Descriptive statistics for the regressors we control for in our models are provided in
Table 5. Their extended name is self-explanatory on their denition.
Table 5 here
The Complementary Health Insurance status according to employer-based or individ-
ually purchased vis-a-vis being either covered by CMU-C or not covered is modeled as a
Multinomial Logit. Following Buchmuller et al. (2004), professional occupational vari-
ables and labour market status are used as instruments - and therefore excluded from
the visit equation, to avoid indentication being based only on non-linearity. The usual
argument here is that di¤erent employment sectors o¤er di¤erent opportunities to enroll
into complementary health insurance schemes and also attract individuals with di¤erent
degrees of risk aversion (Fabbri and Monfardini, 2011). Estimated coe¢ cients (presented
in Table 6) are coherent with theoretical predictions and previous empirical research in
the eld. Income is a good predictor for the CHI status according to a conventional hump
shaped relation.
Table 6 here
Table 7 here
Table 7 contains the estimation results for the count regression. Most of the estimated
coe¢ cients exhibit the expected signs. The most prominent are those related to health
status: self-assessed health, su¤ering from chronic conditions or from some limitation in
daily activities. All of them testify that worse health positively correlates with health-
care consumption. Notice, however, that these e¤ects are likely biased by self-reporting
(see Bago dUva et. al. 2011). Consumption rises, as expected, as the individual ages.
Moreover being highly educated is positively correlated with healthcare consumption, a
common nding in the literature. The rst column displays estimates obtained under
exogeneity of health insurance, the second and third columns contain the second stage
results with inclusion of raw residuals, with variance matrix non corrected and corrected
respectively, while the third and fourth columns corresponds to inclusion of standardized
residuals. Under exogeneity, we nd signicant moral hazard e¤ects arising from supple-
mental insurance coverage either employer provided or individually purchased. Both types
of complementary coverage are associated to a 21-24% increase in the conditional mean
number of visits with respect to the baseline case of no complementary insurance. Once
we allow for the endogeneity of the insurance status results di¤er depending on the den-
ition of residuals adopted. Following the guidelines emerged from our Monte Carlo Study,
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we look at the results obtained with standardized residuals with non corrected standard
errors. We nd support to an identication assumption frequently adopted in the litera-
ture since Ettner (1997): adverse selection is typically argued to be a minor problem for
employer-provided coverage, while being possibly not negligible for individually purchased
plans. Employer insured dummy proves to be exogenous to visits while a positive partial
correlation between standardized rst stage residuals and visitscounts purport the view
that individuals are adversely selected into personally purchased plans.
The outcome of di¤erent exogeneity tests appears at the bottom of Table 7. The most
striking feature is represented by the di¤erent conclusions implied by the alternative de-
nition of residuals adopted. While exogeneity of health insurance is not rejected according
to raw residuals inclusion, whatever the test approach used, the opposite conclusion is
reached with the standarized version of the residuals, with the exception of the Wald
corrected test. Since we have reasons to believe that health insurance is endogenous (on
both theoretical grounds and existing empirical evidence), we reconcile this result with
the higher power displayed in the Monte Carlo study by the 2SRI tests using standardized
residuals.
7 Concluding remarks
We study two stages residuals inclusion (2SRI) approach to testing exogeneity of
multinomial treatment in count data models. The procedure involves estimating the resid-
uals from a discrete choice model, and plugging them as additional variables in the struc-
tural count regression, where their joint signicance can be tested with likelihood based
inference.
The results of our Monte Carlo study show that 2SRI exogeneity tests using Wald,
LR and LM approaches have good nite sample properties when the distribution of the
outcome is correctly specied. In this case, all tests display proper empirical size and
power. We then analyse the performance of 2SRI under misspecication of the second
stage model. We nd that the LM test is the only robust procedure when we ignore over-
dispersion, but this is a strong feature of the data. We also nd evidence that in order
to apply 2SRI exogeneity tests the practitioners should avoid neglecting nonlinearity and
performing OLS estimation.
We investigate also the properties of the testing procedure as sensitive to two alterna-
tive denitions of residuals: raw and standardized. We observe that the power of the test is
generally higher using standardized residuals, which exhibit an higher variance and repre-
sent a better t of the discrete choice model errors. Furthermore, resorting to standardized
residuals leads to a smaller bias of the endogenous treatment dummies coe¢ cients.
The patterns emerging from the Monte Carlo investigation are quite revealing when
we bring the 2SRI method to real data on a leading case study in health economics:
the modeling of visitscount with endogenous health insurance choice. In our empirical
analysis, all tests based on standardized residuals are able to detect endogeneity, while
15
the use of raw, non-standardized residuals leads to the - most likely wrong - opposite
conclusion that health insurance choice is exogenously determined.
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Appendix 1
Table A1: Summary statistics of dependent variables generated in Monte Carlo Study
Distribution of treatment binary variables
DGP1 DGP2
Endogeneity Exogeneity Endogeneity Exogeneity
% of 1
d0 17.08 17.08 17.08 17.08
d1 39.56 39.56 39.56 39.56
d2 34.36 34.36 34.36 34.36
Distribution of outcome count variable - y
DGP1 DGP2
Endogeneity Exogeneity Endogeneity Exogeneity
Mean 7.11 5.39 0.93 0.75
Variance 199.86 59.10 3.92 1.25
% of values
0 21.84 19.68 55.64 55.04
1 14.42 14.58 24.54 27.32
2 10.90 12.54 9.56 10.60
3 8.08 8.02 4.72 3.96
4 6.36 6.90 2.32 1.82
5 5.24 6.18 1.16 0.70
6 3.66 4.92 0.66 0.22
7 3.58 3.92 0.32 0.10
8 2.72 3.58 0.30 0.18
9 2.60 2.90 0.22 0.06
10 1.90 2.32 0.06 0
>10 18.70 14.46 0.42 0
Note: summary statistics are computed on the 5000 observations of the first
replication of the experiment
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Figure 1: Empirical power plot of Wald tests using raw and standardized residuals
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Figure 2: Empirical power plot of LR and LM tests using raw and standardized residuals
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Figure 3: True latent factors against estimated residuals
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Appendix 3
Table A2: NB2 estimator: outcome equation coefficients
DGP 1
Raw Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,3990 0,3730 0,3757 0,6160 0,4432 0,7695
γd2 0,8 0,8 0,7982 0,2989 0,3012 0,8253 0,3533 0,6010
βobs 0,5 0,5 0,5002 0,0280 0,0282 0,5031 0,0335 0,0572
λ1 0,0 -0,1 0,0014 0,3757 0,3784 -0,8571 0,4463 0,7712
λ2 0,0 -0,5 0,0023 0,3022 0,3044 -1,6839 0,3574 0,6065
Standardized Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,4052 0,2751 0,2760 0,3919 0,3225 0,5099
γd2 0,8 0,8 0,8025 0,2274 0,2282 0,6484 0,2700 0,3929
βobs 0,5 0,5 0,4998 0,0236 0,0236 0,5163 0,0280 0,0434
λ1 0,0 -0,1 -0,0024 0,1304 0,1308 -0,2994 0,1525 0,2427
λ2 0,0 -0,5 -0,0010 0,1105 0,1109 -0,7258 0,1314 0,1928
DGP 2
Raw Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,3978 0,4757 0,4789 0,6685 0,5351 0,7506
γd2 0,8 0,8 0,7990 0,3935 0,3964 0,8506 0,4363 0,6008
βobs 0,5 0,5 0,5002 0,0337 0,0340 0,5020 0,0392 0,0539
λ1 0,0 -0,1 0,0043 0,4778 0,4811 -0,9242 0,5396 0,7540
λ2 0,0 -0,5 0,0027 0,3964 0,3991 -1,7203 0,4417 0,6095
Standardized Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,4023 0,3603 0,3616 0,4168 0,3919 0,5250
γd2 0,8 0,8 0,8030 0,2947 0,2957 0,6717 0,3408 0,4311
βobs 0,5 0,5 0,5000 0,0287 0,0288 0,5158 0,0332 0,0437
λ1 0,0 -0,1 -0,0003 0,1718 0,1724 -0,3189 0,1867 0,2514
λ2 0,0 -0,5 -0,0007 0,1416 0,1421 -0,7423 0,1663 0,2126
Note: N. of replications of the Monte Carlo experiment (R) = 5.000; Saple size for each replication (N) = 5.000. Raw
residuals and Standardized residuals are computed after estimation of the first stage equations using, respectively,
τˆij = (dij − pˆij), for j = 0, 1, 2 and τˆij = pˆ−1/2ij (1− pˆij)−1/2(dij − pˆij), for j = 0, 1, 2
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Table A3: Poisson estimator: outcome equation coefficients
DGP 1
Raw Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,3990 0,1562 0,3619 0,7218 0,1348 34,5135
γd2 0,8 0,8 0,7979 0,1304 0,2937 0,8864 0,1129 29,8503
βobs 0,5 0,5 0,5000 0,0108 0,0306 0,5027 0,0092 2,5398
λ1 0,0 -0,1 0,0022 0,1568 0,3638 -0,9984 0,1361 34,4247
λ2 0,0 -0,5 0,0030 0,1312 0,2972 -1,7700 0,1143 29,7677
Standardized Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,4075 0,1193 0,2161 0,4274 0,0988 17,8274
γd2 0,8 0,8 0,8050 0,0971 0,1901 0,6919 0,0892 15,9219
βobs 0,5 0,5 0,4996 0,0092 0,0234 0,5171 0,0079 1,6498
λ1 0,0 -0,1 -0,0031 0,0569 0,1042 -0,3345 0,0473 8,3807
λ2 0,0 -0,5 -0,0021 0,0465 0,0947 -0,7584 0,0436 7,8442
DGP 2
Raw Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,3967 0,4247 0,4307 0,7345 0,3665 3,1866
γd2 0,8 0,8 0,7983 0,3548 0,3598 0,8932 0,3070 2,4532
βobs 0,5 0,5 0,5001 0,0293 0,0297 0,5017 0,0251 0,2390
λ1 0,0 -0,1 0,0053 0,4263 0,4323 -1,0137 0,3699 3,1558
λ2 0,0 -0,5 0,0032 0,3569 0,3619 -1,7804 0,3107 2,5267
Standardized Residuals
True Values Exogeneity Endogeneity
Exog. Endog. Mean S.E. (NC) S.E. (MT) Mean S.E. (NC) S.E. (MT)
γd1 0,4 0,4 0,4020 0,3243 0,3266 0,4323 0,2687 2,1853
γd2 0,8 0,8 0,8032 0,2642 0,2662 0,6942 0,2427 1,6916
βobs 0,5 0,5 0,4999 0,0249 0,0251 0,5166 0,0214 0,1928
λ1 0,0 -0,1 -0,0001 0,1547 0,1559 -0,3381 0,1288 1,0658
λ2 0,0 -0,5 -0,0009 0,1264 0,1274 -0,7613 0,1185 0,8510
Note: N. of replications of the Monte Carlo experiment (R) = 5.000; Saple size for each replication (N) = 5.000. Raw
residuals and Standardized residuals are computed after estimation of the first stage equations using, respectively,
τˆij = (dij − pˆij), for j = 0, 1, 2 and τˆij = pˆ−1/2ij (1− pˆij)−1/2(dij − pˆij), for j = 0, 1, 2
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Figure 4: Overall bias of endogenous dummies coefficients using raw and standardized residuals
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Table 1: NB2 estimator: rejection frequencies of exogeneity tests
Wald Test (Murphy Topel correction )
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0084 0,9594 0,0078 0,9788 0,0080 0,9576 0,0082 0,9752
0,05 0,0460 0,9782 0,0426 0,9918 0,0420 0,9810 0,0472 0,9914
0,10 0,0916 0,9862 0,0956 0,9944 0,0876 0,9878 0,0932 0,9942
Wald Test (no correction)
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0114 0,9954 0,0096 0,9990 0,0096 0,9890 0,0108 0,9954
0,05 0,0520 0,9974 0,0482 0,9998 0,0472 0,9958 0,0506 0,9988
0,10 0,1008 0,9990 0,1014 1,0000 0,0946 0,9972 0,1008 0,9992
Likelihood Ratio Test
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0112 0,9954 0,0096 0,9990 0,0098 0,9894 0,0106 0,9954
0,05 0,0520 0,9974 0,0480 0,9998 0,0472 0,9958 0,0502 0,9988
0,10 0,1006 0,9990 0,1016 1,0000 0,0946 0,9972 0,1006 0,9992
Lagrange Multiplier Test
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0124 0,9806 0,0108 0,9954 0,0104 0,9720 0,0100 0,9910
0,05 0,0544 0,9924 0,0498 0,9990 0,0484 0,9906 0,0510 0,9982
0,10 0,1022 0,9954 0,1032 0,9992 0,0952 0,9954 0,1042 0,9990
Note: N. of replications of the Monte Carlo experiment (R) = 5.000; Saple size for each replication (N) = 5.000. Raw residuals and Standardized residuals are computed after
estimation of the first stage equations using, respectively: τˆij = (dij − pˆij), for j = 0, 1, 2 and τˆij = pˆ−1/2ij (1− pˆij)−1/2(dij − pˆij), for j = 0, 1, 2
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Table 2: Poisson estimator: rejection frequencies of exogeneity tests
Wald Test (Murphy Topel correction )
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0000 0,0000 0,0000 0,0000 0,0174 0,7370 0,0208 0,8194
0,05 0,0076 0,0000 0,0006 0,0000 0,0816 0,8454 0,0900 0,8940
0,10 0,0456 0,0000 0,0190 0,0000 0,1462 0,8896 0,1562 0,9206
Wald Test (no correction)
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,5494 0,9998 0,5498 0,9998 0,0258 0,9966 0,0298 0,9988
0,05 0,6696 1,0000 0,6822 0,9998 0,0932 0,9980 0,1010 0,9994
0,10 0,7362 1,0000 0,7412 1,0000 0,1628 0,9986 0,1690 0,9994
Likelihood Ratio Test
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,5494 0,9998 0,5494 0,9998 0,0260 0,9966 0,0260 0,9966
0,05 0,6696 1,0000 0,6696 1,0000 0,0928 0,9980 0,0928 0,9980
0,10 0,7362 1,0000 0,7362 1,0000 0,1632 0,9986 0,1632 0,9986
Lagrange Multiplier Test
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,0128 0,9118 0,0124 0,9626 0,0100 0,9372 0,0098 0,9750
0,05 0,0524 0,9660 0,0586 0,9884 0,0482 0,9740 0,0494 0,9918
0,10 0,1072 0,9776 0,1104 0,9946 0,0940 0,9834 0,1034 0,9960
Note: N. of replications of the Monte Carlo experiment (R) = 5.000; Saple size for each replication (N) = 5.000. Raw residuals and Standardized residuals are computed
after estimation of the first stage equations using, respectively: τˆij = (dij − pˆij), for j = 0, 1, 2 and τˆij = pˆ−1/2ij (1− pˆij)−1/2(dij − pˆij), for j = 0, 1, 2
ii
Table 3: OLS estimator: rejection frequencies of exogeneity tests
F Test (Murphy Topel correction )
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,1092 0,5480 0,2698 0,6214 0,0854 0,6326 0,2248 0,7202
0,05 0,3060 0,7438 0,5348 0,8082 0,2536 0,8056 0,4704 0,8638
0,10 0,4438 0,8264 0,6746 0,8738 0,3752 0,8704 0,6114 0,9116
F Test (no correction)
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,1258 0,5780 0,3028 0,6566 0,1002 0,6600 0,2468 0,7448
0,05 0,3188 0,7576 0,5530 0,8244 0,2652 0,8172 0,4838 0,8760
0,10 0,4520 0,8352 0,6820 0,8830 0,3848 0,8780 0,6198 0,9192
Lagrange Multiplier Test
DGP 1 DGP 2
Raw Residuals Standardized Residuals Raw Residuals Standardized Residuals
Nom. Size Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power Emp. Size Emp. Power
0,01 0,1258 0,5780 0,3030 0,6566 0,1002 0,6604 0,2468 0,7450
0,05 0,3190 0,7578 0,5534 0,8248 0,2660 0,8174 0,4840 0,8762
0,10 0,4520 0,8352 0,6822 0,8830 0,3850 0,8780 0,6202 0,9196
Note: N. of replications of the Monte Carlo experiment (R) = 5.000; Saple size for each replication (N) = 5.000. Raw residuals and Standardized residuals are computed
after estimation of the first stage equations using, respectively: τˆij = (dij − pˆij), for j = 0, 1, 2 and τˆij = pˆ−1/2ij (1− pˆij)−1/2(dij − pˆij), for j = 0, 1, 2
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Table 4: Descriptive statistics of the dependent variables
Treatment Variable
Mean Std. Dev. Min. Max.
Employer Insured 0,5549 0,4970 0 1
Individually Purchased 0,3374 0,4729 0 1
Uninsured 0,1077 0,3100 0 1
Utilization Measure
Mean Std. Dev. Min. Max.
Total N. of Consultations 5,2311 5,9175 0 104
Sample Distribution
Value Freq. Percentage Cum. Perc.
0 717 11,11 11,11
1 788 12,21 23,32
2 892 13,82 37,13
3 684 10,6 47,73
4 734 11,37 59,1
5 491 7,61 66,71
6 461 7,14 73,85
7 299 4,63 78,48
8 241 3,73 82,22
9 145 2,25 84,46
10 160 2,48 86,94
More than 10 113 13.06 1,00
Total 6.455 100
Table 5: Descriptive statistics of the regressors
Variable Mean Std. Dev. Min. Max.
Demographic Characteristics
Male 0,4973 0,5000 0 1
Age 46,4632 13,0897 25 74
Married 0,8215 0,3829 0 1
Children 0,5859 0,4926 0 1
Family size 3,0223 1,2843 1 10
Education
No school 0,0116 0,1072 0 1
Primary school 0,1287 0,3349 0 1
Secondary school 0,3565 0,4790 0 1
High school 0,1686 0,3744 0 1
Higher education 0,3249 0,4684 0 1
Other/unknown education 0,0098 0,0983 0 1
Income
HH Income / Comsumption Unit 1616,662 938,655 45,560 15033,330
Quintile
1st 944,450
2nd 1293,810
3rd 1622,670
4th 2138,890
5th 15033,330
Income Unknown 0,0541 0,2262 0 1
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Table 5: Descriptive statistics of the regressors
Variable Mean Std. Dev. Min. Max.
Health Characteristics
Self Assessed Health: Poor-Fair 0,2059 0,4044 0 1
Self Assessed Health: Good 0,5774 0,4940 0 1
Self Assessed Health: Excellent 0,2167 0,4120 0 1
Chronic Condition 0,2542 0,4355 0 1
Limitation with daily activities 0,1431 0,3502 0 1
Smoker 0,2682 0,4430 0 1
Former Smoker 0,2968 0,4569 0 1
Light Smoker 0,0730 0,2601 0 1
Heavy Smoker 0,0858 0,2801 0 1
Labor Market Status
Inactive 0,0593 0,2363 0 1
Unemployed 0,0736 0,2611 0 1
Retired 0,1766 0,3814 0 1
Employed 0,6905 0,4623 0 1
Professional Occupation
Private Employee 0,6945 0,4607 0 1
Private Employee - Blue Collar 0,2561 0,4365 0 1
Private Employee - White Collar 0,3182 0,4658 0 1
Privare Employee - Executive 0,1148 0,3188 0 1
Self Employed 0,1038 0,3050 0 1
Self Employed - Farmers 0,0313 0,1741 0 1
Self Employed - Artisans 0,0248 0,1555 0 1
Self Employed - Commerce & Industry 0,0197 0,1389 0 1
Self Employed - Profession 0,0175 0,1312 0 1
Self Employed - Other 0,0105 0,1021 0 1
Public Sector Employee 0,2017 0,4013 0 1
Public Sector - level 1 0,0218 0,1462 0 1
Public Sector - level 2 0,1284 0,3346 0 1
Public Sector - level 3 0,0499 0,2177 0 1
?????
Exempted - any 0,1600 0,3667 0 1
Exempted due to Long Term Desease 0,1196 0,3245 0 1
Exempted due to other reasons 0,0564 0,2307 0 1
CMU Complementaire 0,0576 0,2331 0 1
Regime Generale 0,8768 0,3286 0 1
Observations 6455
Table 6: MNL model for Complementary Health Insurance
VARIABLES Employer Insured Individually Purchased
Male -0.229* -0.252**
[0.121] [0.121]
Age 0.161*** 0.028
[0.042] [0.041]
Age^2 -0.002*** -0.000
[0.000] [0.000]
Married 1.282*** 0.844***
[0.162] [0.161]
Children 0.265 0.191
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Table 6: MNL model for Complementary Health Insurance
VARIABLES Employer Insured Individually Purchased
[0.191] [0.192]
Familysize -0.193*** -0.294***
[0.069] [0.071]
Secondary School 0.401* 0.495**
[0.230] [0.229]
High School 0.633** 0.591**
[0.285] [0.285]
Higher Education 0.427 0.325
[0.284] [0.283]
Other / Unknown Education -0.701 -0.235
[0.465] [0.452]
Income per C.U. - 20th - 40th percentile 0.457** 0.446**
[0.201] [0.197]
Income per C.U. - 40th - 60th percentile 1.323*** 0.864***
[0.249] [0.247]
Income per C.U. - 60th - 80th percentile 1.661*** 1.125***
[0.295] [0.291]
Income per C.U.- 80th - 100th percentile 1.449*** 0.642**
[0.296] [0.298]
Income Uknown 0.687*** 0.545**
[0.263] [0.254]
Self Assessed Health Status - Good 0.141 0.198
[0.164] [0.165]
Self Assessed Health Status - Poor-Fair -0.183 -0.005
[0.230] [0.228]
Chronic Condition 0.260 0.141
[0.189] [0.188]
Limited with Daily Activities -0.152 -0.219
[0.206] [0.204]
Former Smoker 0.199 0.123
[0.156] [0.158]
Light Smoker -0.189 -0.051
[0.231] [0.232]
Heavy Smoker -0.541*** -0.577***
[0.196] [0.195]
Inactive -0.963*** -0.503**
[0.239] [0.240]
Unemployed -2.340*** -0.958***
[0.197] [0.180]
Retired -0.141 0.337
[0.344] [0.343]
Private Employee 0.811* 0.004
[0.461] [0.433]
Private Employee - white collar 0.267 0.254
[0.170] [0.170]
Private Employee - executive 0.420 -0.114
[0.282] [0.287]
Public Sector Employee 1.033* 0.320
[0.600] [0.572]
Public Sector Employee - level 2 0.423 0.312
[0.473] [0.469]
Public Sector Employee - level 3 0.153 -0.267
[0.588] [0.597]
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Table 6: MNL model for Complementary Health Insurance
VARIABLES Employer Insured Individually Purchased
Self Employed - artisans -0.122 -0.290
[0.495] [0.469]
Self Employed - commerce & industry 0.282 -0.236
[0.530] [0.497]
Self Employed - profession -0.373 -0.140
[0.563] [0.537]
Self Employed - other -0.762 -0.558
[0.647] [0.618]
Exempted - long term desease -0.039 -0.053
[0.227] [0.224]
Exempted - other -0.790*** -0.760***
[0.280] [0.271]
CMU complementaire -4.196*** -4.944***
[0.388] [0.470]
Regime Generale 0.358 0.014
[0.267] [0.262]
Constant -4.108*** 0.304
[0.967] [0.921]
Observations 6,455 6,455
Pseudologlik -4.534.387 -4.534.387
Note: Robust standard errors in brackets; *** p<0.01, ** p<0.05, * p<0.1
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Table 7: Negative Binomial 2 regressions for total numberof consultations (G.P. + specialists)
VARIABLES Exogenous Raw Res. (NC s.e.) Raw Res. (MT s.e.) Std. Res. (NC s.e.) Std.Res. (MT s.e.)
Employer Insured 0.2097*** 0.0206 0.0206 0.3522*** 0.3522***
[0.067] [0.190] [0.220] [0.114] [0.131]
Individually Purchased 0.2407*** -0.1305 -0.1305 0.1369* 0.1369
[0.068] [0.315] [0.339] [0.082] [0.110]
Male -0.5030*** -0.5012*** -0.5012*** -0.4894*** -0.4894***
[0.027] [0.027] [0.033] [0.026] [0.027]
Age -0.0383*** -0.0440*** -0.0440*** -0.0370*** -0.0370***
[0.008] [0.009] [0.010] [0.008] [0.010]
Age ^2 0.0004*** 0.0004*** 0.0004*** 0.0003*** 0.0003***
[0.000] [0.000] [0.000] [0.000] [0.000]
Married 0.1044** 0.0759 0.0759 0.0778 0.0778
[0.050] [0.056] [0.083] [0.050] [0.056]
Children -0.0402 -0.0509 -0.0509 -0.0442 -0.0442
[0.047] [0.047] [0.082] [0.047] [0.050]
Family Size -0.0205 -0.0186 -0.0186 -0.0109 -0.0109
[0.019] [0.020] [0.026] [0.020] [0.023]
Secondary School 0.0499 0.0449 0.0449 0.0304 0.0304
[0.040] [0.041] [0.043] [0.042] [0.046]
High School 0.0522 0.0411 0.0411 0.0257 0.0257
[0.050] [0.051] [0.062] [0.049] [0.053]
Higher Education 0.1804*** 0.1662*** 0.1662*** 0.1655*** 0.1655***
[0.046] [0.046] [0.049] [0.047] [0.052]
Other / Unknown Education 0.0924 0.1101 0.1101 0.0930 0.0930
[0.116] [0.117] [0.116] [0.116] [0.120]
HH Inc./ CU: 2nd quintile 0.0388 0.0211 0.0211 0.0187 0.0187
[0.049] [0.052] [0.053] [0.049] [0.061]
HH Inc./ CU: 3rd quintile -0.0199 -0.0625 -0.0625 -0.0448 -0.0448
[0.047] [0.054] [0.057] [0.049] [0.058]
HH Inc./ CU: 4th quintile -0.0597 -0.1086* -0.1086* -0.0912* -0.0912
[0.048] [0.056] [0.060] [0.051] [0.061]
HH Inc./ CU: 5th quintile 0.0114 -0.0435 -0.0435 0.0090 0.0090
[0.057] [0.062] [0.082] [0.061] [0.068]
HH Inc./ CU: unknown -0.0747 -0.0973 -0.0973 -0.0952 -0.0952
[0.062] [0.065] [0.066] [0.062] [0.065]
Self Assessed Health Status: Good 0.3170*** 0.3166*** 0.3166*** 0.3098*** 0.3098***
[0.037] [0.037] [0.048] [0.037] [0.043]
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Table 7: Negative Binomial 2 regressions for total numberof consultations (G.P. + specialists)
VARIABLES Exogenous Raw Res. (NC s.e.) Raw Res. (MT s.e.) Std. Res. (NC s.e.) Std.Res. (MT s.e.)
Self Assessed Health Status: Poor-Fair 0.6768*** 0.6837*** 0.6837*** 0.6760*** 0.6760***
[0.058] [0.059] [0.096] [0.058] [0.060]
Chronic Condition 0.3261*** 0.3234*** 0.3234*** 0.3208*** 0.3208***
[0.032] [0.032] [0.044] [0.032] [0.039]
Limitation with Daily Activities 0.3826*** 0.3841*** 0.3841*** 0.3893*** 0.3893***
[0.041] [0.042] [0.047] [0.042] [0.045]
Former Smoker 0.1451*** 0.1412*** 0.1412*** 0.1444*** 0.1444***
[0.028] [0.028] [0.037] [0.028] [0.030]
Light Smoker 0.0369 0.0419 0.0419 0.0369 0.0369
[0.054] [0.054] [0.056] [0.053] [0.072]
Heavy Smoker 0.0183 0.0299 0.0299 0.0375 0.0375
[0.061] [0.061] [0.063] [0.062] [0.086]
Exempted - long term desease 0.2496*** 0.2506*** 0.2506*** 0.2497*** 0.2497***
[0.044] [0.044] [0.045] [0.044] [0.054]
Exempted - other 0.1582*** 0.1778*** 0.1778*** 0.1967*** 0.1967***
[0.061] [0.064] [0.065] [0.061] [0.066]
CMU complementaire 0.2269*** 0.4116 0.4116 0.4016*** 0.4016***
[0.088] [0.271] [0.293] [0.113] [0.128]
Regime Generale 0.1009** 0.0739 0.0739 0.1016** 0.1016**
[0.041] [0.046] [0.046] [0.043] [0.050]
Ist Step "Raw" Res. - Outcome 1 0.1615 0.1615
[0.175] [0.198]
Ist Step "Raw" Res. - Outcome 2 0.3509 0.3509
[0.308] [0.343]
Ist Step "Standardized" Res. - Outcome 1 -0.0492 -0.0492
[0.037] [0.042]
Ist Step "Standardized" Res. - Outcome 2 0.0211** 0.0211
[0.010] [0.017]
Constant 1.7696*** 2.0852*** 2.0852*** 1.7276*** 1.7276***
[0.181] [0.276] [0.290] [0.218] [0.256]
ln (alpha) -0.7249*** -0.7259*** -0.7259*** -0.7284*** -0.7284***
[0.041] [0.041] [0.089] [0.041] [0.040]
Observations 6,455 6,455 6,455 6,455 6,455
Exogeneity tests
Wald test 2.806 1.891 5859** 2.019
Wald test - p value 0.246 0.388 0.053 0.364
LR test 4.097 4.097 14338*** 14338***
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Table 7: Negative Binomial 2 regressions for total numberof consultations (G.P. + specialists)
VARIABLES Exogenous Raw Res. (NC s.e.) Raw Res. (MT s.e.) Std. Res. (NC s.e.) Std.Res. (MT s.e.)
LR test - p value 0.129 0.129 0.001 0.001
LM test 3.403 3.403 8620** 8620**
LM test- pvalue 0.182 0.182 0.013 0.013
Note: *** p<0.01, ** p<0.05, * p<0.1
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